Healthdirect Australia is not responsible for the content and advertising on the external website you are now entering.
Active ingredients: dornase alfa
What it is used for
Chronic administration of Pulmozyme is indicated for the management of demonstrated respiratory complications in cystic fibrosis. Continued use should depend on demonstrating a sustained benefit based on clinical response and, if able to be performed, pulmonary function tests.
How to take it
The way to take this medicine is: Inhalation.
- Store at 2 to 8 degrees Celsius
- Protect from Light
- Shelf lifetime is 3 Years.
You should seek medical advice in relation to medicines and use only as directed by a healthcare professional.
Always read the label. If symptoms persist see your healthcare professional.
Clear, colourless liquid.
Do I need a prescription?
This medicine is available from a pharmacist and requires a prescription. It is
Is this medicine subsidised?
This medicine was verified as being available on the PBS (Pharmaceutical Benefits Scheme) on November 1, 2021. To learn more about this subsidy, visit the Pharmaceutical Benefits Scheme (PBS) website.
Pregnant or planning a pregnancy?
For the active ingredient dornase alfa
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
Consumer Medicines Information (CMI)
For side effects, taking other medicines and more
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems